ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Gross of the placeholder expense ratio and trading costs · not investor results
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1NFLX | NETFLIX INC | Communication Services | $257.43B | 15.11% |
2GEV | GE VERNOVA INC | Utilities | $216.64B | 12.72% |
3ISRG | INTUITIVE SURGICAL INC | Healthcare | $152.49B | 8.95% |
4SNOW | SNOWFLAKE INC | Technology | $105.38B | 6.19% |
5ETR | ENTERGY CORP | Utilities | $53.49B | 3.14% |
6WDAY | WORKDAY INC | Technology | $45.94B | 2.70% |
7FIX | COMFORT SYSTEMS USA INC | Industrials | $39.47B | 2.32% |
8RBLX | ROBLOX CORP | Communication Services | $36.80B | 2.16% |
9CRWV | COREWEAVE INC | Technology | $31.22B | 1.83% |
10DXCM | DEXCOM INC | Healthcare | $30.35B | 1.78% |
11CPAY | CORPAY INC | Technology | $29.17B | 1.71% |
12ROIV | ROIVANT SCIENCES LTD | Healthcare | $28.98B | 1.70% |
13VRSN | VERISIGN INC | Technology | $28.03B | 1.65% |
14CPNG | COUPANG INC | Consumer Cyclical | $27.40B | 1.61% |
15INSM | INSMED INC | Healthcare | $25.90B | 1.52% |
16UTHR | UNITED THERAPEUTICS CORP | Healthcare | $25.27B | 1.48% |
17ROKU | ROKU INC | Communication Services | $23.93B | 1.40% |
18JBHT | HUNT J B TRANSPORT SERVICES INC | Industrials | $21.22B | 1.25% |
19DD | DUPONT DE NEMOURS INC | Basic Materials | $20.50B | 1.20% |
20NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.15B | 1.01% |
21W | WAYFAIR INC | Consumer Cyclical | $15.25B | 0.90% |
22BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $14.22B | 0.83% |
23SITM | SITIME CORP | Technology | $14.22B | 0.83% |
24PCOR | PROCORE TECHNOLOGIES INC | Technology | $11.55B | 0.68% |
25PINS | PINTEREST INC | Communication Services | $10.97B | 0.64% |
26R | RYDER SYSTEM INC | Industrials | $10.66B | 0.63% |
27HUBS | HUBSPOT INC | Technology | $10.54B | 0.62% |
28PCVX | VAXCYTE INC | Healthcare | $10.24B | 0.60% |
29TTC | TORO CO | Industrials | $10.11B | 0.59% |
30KNX | KNIGHT-SWIFT TRANSPORTATION HOLDINGS INC | Industrials | $10.05B | 0.59% |
31OSCR | OSCAR HEALTH INC | Healthcare | $9.92B | 0.58% |
32MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $9.88B | 0.58% |
33HNGE | HINGE HEALTH INC | Healthcare | $9.83B | 0.58% |
34OC | OWENS CORNING | Industrials | $9.06B | 0.53% |
35APPF | APPFOLIO INC | Technology | $7.90B | 0.46% |
36SM | SM ENERGY CO | Energy | $7.70B | 0.45% |
37RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | $7.62B | 0.45% |
38CLF | CLEVELAND-CLIFFS INC | Basic Materials | $7.46B | 0.44% |
39KOD | KODIAK SCIENCES INC | Healthcare | $6.80B | 0.40% |
40RIOT | RIOT PLATFORMS INC | Financial Services | $6.69B | 0.39% |
41RNG | RINGCENTRAL INC | Technology | $6.41B | 0.38% |
42LYFT | LYFT INC | Technology | $6.28B | 0.37% |
43ACI | ALBERTSONS COMPANIES INC | Consumer Defensive | $6.20B | 0.36% |
44WFRD | WEATHERFORD INTERNATIONAL PLC | Energy | $6.20B | 0.36% |
45HRB | H&R BLOCK INC | Consumer Cyclical | $6.17B | 0.36% |
46DOCS | DOXIMITY INC | Healthcare | $5.92B | 0.35% |
47VRNS | VARONIS SYSTEMS INC | Technology | $5.66B | 0.33% |
48SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $5.27B | 0.31% |
49PEGA | PEGASYSTEMS INC | Technology | $5.24B | 0.31% |
50LQDA | LIQUIDIA CORP | Healthcare | $5.24B | 0.31% |
51CRGY | CRESCENT ENERGY CO | Energy | $5.09B | 0.30% |
52GFF | GRIFFON CORP | Industrials | $4.75B | 0.28% |
53CORZ | CORE SCIENTIFIC INC | Technology | $4.63B | 0.27% |
54HIMS | HIMS & HERS HEALTH INC | Consumer Defensive | $4.63B | 0.27% |
55IONS | IONIS PHARMACEUTICALS INC | Healthcare | $4.55B | 0.27% |
56QTWO | Q2 HOLDINGS INC | Technology | $4.51B | 0.26% |
57SPHR | SPHERE ENTERTAINMENT CO | Communication Services | $4.49B | 0.26% |
58CAR | AVIS BUDGET GROUP INC | Industrials | $4.44B | 0.26% |
59MTRN | MATERION CORP | Basic Materials | $4.34B | 0.25% |
60CRC | CALIFORNIA RESOURCES CORP | Energy | $4.23B | 0.25% |
61LION | LIONSGATE STUDIOS CORP | Communication Services | $4.20B | 0.25% |
62CDNA | CAREDX INC | Healthcare | $4.19B | 0.25% |
63PTEN | PATTERSON UTI ENERGY INC | Energy | $4.05B | 0.24% |
64NP | NEPTUNE INSURANCE HOLDINGS INC | Financial Services | $3.94B | 0.23% |
65TARS | TARSUS PHARMACEUTICALS INC | Healthcare | $3.79B | 0.22% |
66ENPH | ENPHASE ENERGY INC | Technology | $3.54B | 0.21% |
67RGTI | RIGETTI COMPUTING INC | Technology | $3.54B | 0.21% |
68VKTX | VIKING THERAPEUTICS INC | Healthcare | $3.52B | 0.21% |
69FRSH | FRESHWORKS INC | Technology | $3.32B | 0.20% |
70HOG | HARLEY-DAVIDSON INC | Consumer Cyclical | $3.28B | 0.19% |
71REZI | RESIDEO TECHNOLOGIES INC | Industrials | $3.27B | 0.19% |
72CLMT | CALUMET INC | Energy | $3.21B | 0.19% |
73IRTC | IRHYTHM HOLDINGS INC | Healthcare | $3.15B | 0.18% |
74DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.03B | 0.18% |
75IPGP | IPG PHOTONICS CORP | Technology | $3.01B | 0.18% |
76LOPE | GRAND CANYON EDUCATION INC | Consumer Defensive | $3.00B | 0.18% |
77ARCB | ARCBEST CORP | Industrials | $2.97B | 0.17% |
78VERX | VERTEX INC | Technology | $2.88B | 0.17% |
79XNCR | XENCOR INC | Healthcare | $2.86B | 0.17% |
80MARA | MARA HOLDINGS INC | Financial Services | $2.79B | 0.16% |
81PGNY | PROGYNY INC | Healthcare | $2.69B | 0.16% |
82TALO | TALOS ENERGY INC | Energy | $2.65B | 0.16% |
83NOG | NORTHERN OIL & GAS INC | Energy | $2.62B | 0.15% |
84RCUS | ARCUS BIOSCIENCES INC | Healthcare | $2.56B | 0.15% |
85SDGR | SCHRODINGER INC | Healthcare | $2.32B | 0.14% |
86PRGO | PERRIGO CO PLC | Healthcare | $2.25B | 0.13% |
87LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Consumer Cyclical | $2.24B | 0.13% |
88PPTA | PERPETUA RESOURCES CORP | Basic Materials | $2.23B | 0.13% |
89ASAN | ASANA INC | Technology | $2.21B | 0.13% |
90AMPL | AMPLITUDE INC | Technology | $2.21B | 0.13% |
91VERA | VERA THERAPEUTICS INC | Healthcare | $2.10B | 0.12% |
92REPL | REPLIMUNE GROUP INC | Healthcare | $2.08B | 0.12% |
93VIR | VIR BIOTECHNOLOGY INC | Healthcare | $2.08B | 0.12% |
94AI | C3AI INC | Technology | $1.94B | 0.11% |
95ARHS | ARHAUS INC | Consumer Cyclical | $1.92B | 0.11% |
96MTX | MINERALS TECHNOLOGIES INC | Basic Materials | $1.92B | 0.11% |
97AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $1.90B | 0.11% |
98REAL | THEREALREAL INC | Consumer Cyclical | $1.78B | 0.10% |
99CLSK | CLEANSPARK INC | Financial Services | $1.76B | 0.10% |
100RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $1.66B | 0.10% |
101ENOV | ENOVIS CORP | Healthcare | $1.59B | 0.09% |
102TDOC | TELADOC HEALTH INC | Healthcare | $1.58B | 0.09% |
103ABSI | ABSCI CORP | Healthcare | $1.57B | 0.09% |
104SVV | SAVERS VALUE VILLAGE INC | Consumer Cyclical | $1.55B | 0.09% |
105PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.46B | 0.09% |
106NVAX | NOVAVAX INC | Healthcare | $1.45B | 0.08% |
107DMLP | DORCHESTER MINERALS LP | Energy | $1.43B | 0.08% |
108ANAB | ANAPTYSBIO INC | Healthcare | $1.43B | 0.08% |
109WOLF | WOLFSPEED INC | Technology | $1.42B | 0.08% |
110NVCR | NOVOCURE LTD | Healthcare | $1.37B | 0.08% |
111TRS | TRIMAS CORP | Consumer Cyclical | $1.35B | 0.08% |
112CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.29B | 0.08% |
113INNV | INNOVAGE HOLDING CORP | Healthcare | $1.28B | 0.08% |
114NBR | NABORS INDUSTRIES LTD | Energy | $1.26B | 0.07% |
115UPWK | UPWORK INC | Industrials | $1.24B | 0.07% |
116BJRI | BJS RESTAURANTS INC | Consumer Cyclical | $1.20B | 0.07% |
117UAN | CVR PARTNERS LP | Basic Materials | $1.18B | 0.07% |
118TH | TARGET HOSPITALITY CORP | Industrials | $1.17B | 0.07% |
119FUN | SIX FLAGS ENTERTAINMENT CORPORATION | Consumer Cyclical | $1.14B | 0.07% |
120YELP | YELP INC | Communication Services | $1.10B | 0.06% |
121AHCO | ADAPTHEALTH CORP | Healthcare | $1.07B | 0.06% |
122VSTM | VERASTEM INC | Healthcare | $1.06B | 0.06% |
123HPK | HIGHPEAK ENERGY INC | Energy | $1.05B | 0.06% |
124CBLL | CERIBELL INC | Healthcare | $1.02B | 0.06% |
125CYRX | CRYOPORT INC | Industrials | $1.02B | 0.06% |
126REPX | RILEY EXPLORATION PERMIAN INC | Energy | $977M | 0.06% |
127KRO | KRONOS WORLDWIDE INC | Basic Materials | $968M | 0.06% |
128CMP | COMPASS MINERALS INTERNATIONAL INC | Basic Materials | $968M | 0.06% |
129SWIM | LATHAM GROUP INC | Industrials | $964M | 0.06% |
130MMI | MARCUS & MILLICHAP INC | Real Estate | $920M | 0.05% |
131SXC | SUNCOKE ENERGY INC | Basic Materials | $913M | 0.05% |
132CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $888M | 0.05% |
133NWPX | NWPX INFRASTRUCTURE INC | Industrials | $879M | 0.05% |
134GRNT | GRANITE RIDGE RESOURCES INC | Energy | $856M | 0.05% |
135MITK | MITEK SYSTEMS INC | Technology | $824M | 0.05% |
136HTLD | HEARTLAND EXPRESS INC | Industrials | $797M | 0.05% |
137FMC | FMC CORP | Basic Materials | $787M | 0.05% |
138ULH | UNIVERSAL LOGISTICS HOLDINGS INC | Industrials | $783M | 0.05% |
139LINC | LINCOLN EDUCATIONAL SERVICES CORP | Consumer Defensive | $707M | 0.04% |
140KRT | KARAT PACKAGING INC | Consumer Cyclical | $707M | 0.04% |
141SWBI | SMITH & WESSON BRANDS INC | Industrials | $698M | 0.04% |
142FLGT | FULGENT GENETICS INC | Healthcare | $694M | 0.04% |
143AESI | ATLAS ENERGY SOLUTIONS INC | Energy | $689M | 0.04% |
144KURA | KURA ONCOLOGY INC | Healthcare | $683M | 0.04% |
145PKOH | PARK OHIO HOLDINGS CORP | Industrials | $679M | 0.04% |
146LEGH | LEGACY HOUSING CORP | Consumer Cyclical | $675M | 0.04% |
147ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | $664M | 0.04% |
148DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | $663M | 0.04% |
149CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $662M | 0.04% |
150QMCO | QUANTUM CORP | Technology | $658M | 0.04% |
151VTS | VITESSE ENERGY INC | Energy | $650M | 0.04% |
152SRZN | SURROZEN INC | Healthcare | $604M | 0.04% |
153EGY | VAALCO ENERGY INC | Energy | $582M | 0.03% |
154MLR | MILLER INDUSTRIES INC | Consumer Cyclical | $551M | 0.03% |
155MYGN | MYRIAD GENETICS INC | Healthcare | $545M | 0.03% |
156PAYS | PAYSIGN INC | Technology | $540M | 0.03% |
157TKNO | ALPHA TEKNOVA INC | Healthcare | $522M | 0.03% |
158SRTA | STRATA CRITICAL MEDICAL INC | Healthcare | $515M | 0.03% |
159RCEL | AVITA MEDICAL INC | Healthcare | $509M | 0.03% |
160PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | $506M | 0.03% |
161ANGO | ANGIODYNAMICS INC | Healthcare | $504M | 0.03% |
162DMAC | DIAMEDICA THERAPEUTICS INC | Healthcare | $503M | 0.03% |
163ASPN | ASPEN AEROGELS INC | Industrials | $498M | 0.03% |
164ZIP | ZIPRECRUITER INC | Industrials | $461M | 0.03% |
165ARVN | ARVINAS INC | Healthcare | $450M | 0.03% |
166SI | SHOULDER INNOVATIONS INC | Healthcare | $441M | 0.03% |
167LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $385M | 0.02% |
168AMCX | AMC GLOBAL MEDIA INC | Communication Services | $384M | 0.02% |
169SPIR | SPIRE GLOBAL INC | Industrials | $375M | 0.02% |
170RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $371M | 0.02% |
171CTRN | CITI TRENDS INC | Consumer Cyclical | $359M | 0.02% |
172MEC | MAYVILLE ENGINEERING COMPANY INC | Industrials | $357M | 0.02% |
173TMCI | TREACE MEDICAL CONCEPTS INC | Healthcare | $350M | 0.02% |
174VMD | VIEMED HEALTHCARE INC | Healthcare | $345M | 0.02% |
175GTE | GRAN TIERRA ENERGY INC | Energy | $339M | 0.02% |
176CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $324M | 0.02% |
177PNRG | PRIMEENERGY RESOURCES CORP | Energy | $304M | 0.02% |
178EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $303M | 0.02% |
179MLP | MAUI LAND & PINEAPPLE CO INC | Real Estate | $299M | 0.02% |
180PAMT | PAMT CORP | Industrials | $298M | 0.02% |
181TBCH | TURTLE BEACH CORP | Technology | $296M | 0.02% |
182PMTS | CPI CARD GROUP INC | Financial Services | $293M | 0.02% |
183CUB | LIONHEART HOLDINGS | Financial Services | $287M | 0.02% |
184ENHA | ENHANCED GROUP INC | Consumer Defensive | $279M | 0.02% |
185GTERA | GLOBA TERRA ACQUISITION CORP | Financial Services | $249M | 0.01% |
186SOCA | SOLARIUS CAPITAL ACQUISITION CORP | Financial Services | $245M | 0.01% |
187AOUT | AMERICAN OUTDOOR BRANDS INC | Consumer Cyclical | $240M | 0.01% |
188RXST | RXSIGHT INC | Healthcare | $226M | 0.01% |
189GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $224M | 0.01% |
190LOVE | LOVESAC CO | Consumer Cyclical | $220M | 0.01% |
191VRA | VERA BRADLEY INC | Consumer Cyclical | $217M | 0.01% |
192PDEX | PRO DEX INC | Healthcare | $216M | 0.01% |
193TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $202M | 0.01% |
194DIBS | 1STDIBSCOM INC | Consumer Cyclical | $199M | 0.01% |
195ALTG | ALTA EQUIPMENT GROUP INC | Industrials | $186M | 0.01% |
196QUIK | QUICKLOGIC CORP | Technology | $182M | 0.01% |
197AEYE | AUDIOEYE INC | Technology | $181M | 0.01% |
198RAIL | FREIGHTCAR AMERICA INC | Industrials | $175M | 0.01% |
199DMRC | DIGIMARC CORP | Technology | $167M | 0.01% |
200COOK | TRAEGER INC | Consumer Cyclical | $162M | 0.01% |
201AP | AMPCO PITTSBURGH CORP | Industrials | $159M | 0.01% |
202ALMU | AELUMA INC | Technology | $146M | 0.01% |
203SRI | STONERIDGE INC | Consumer Cyclical | $145M | 0.01% |
204TCX | TUCOWS INC | Technology | $139M | 0.01% |
205CUE | CUE BIOPHARMA INC | Healthcare | $127M | 0.01% |
206SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $123M | 0.01% |
207AKA | AKA BRANDS HOLDING CORP | Consumer Cyclical | $98M | 0.01% |
208LAKE | LAKELAND INDUSTRIES INC | Consumer Cyclical | $92M | 0.01% |
209RLYB | RALLYBIO CORP | Healthcare | $84M | 0.00% |
210ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $81M | 0.00% |
211GOSS | GOSSAMER BIO INC | Healthcare | $69M | 0.00% |
212PRTS | CARPARTSCOM INC | Consumer Cyclical | $68M | 0.00% |
213LFVN | LIFEVANTAGE CORP | Consumer Defensive | $64M | 0.00% |
214COCH | ENVOY MEDICAL INC | Healthcare | $53M | 0.00% |
215TPCS | TECHPRECISION CORP | Industrials | $53M | 0.00% |
216YARW | YARROW BIOSCIENCE INC | Healthcare | $52M | 0.00% |
Full long-leg book as of November 2026 · cap-weighted · total market cap $1.70T. Hypothetical model holdings — not a registered fund’s portfolio.
Size × value map of the long-leg book
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
Days required to liquidate the largest position at 20% of one day's dollar volume.
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20261113T032607 rows=2198308 asof=202611 issuers=20261113T063725 rates=20261113T063725
Measured on the 2026-11 formation date across 216 holdings (cap-weighted). A different formation date can produce different verdicts.
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 335 monthly observations · about 3.4 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 16%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Did the edge survive the paper coming out?
There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 10.2% | 14.8% |
| 3 yearsp.a. | 24.3% | -1.5% |
| 5 yearsp.a. | 14.5% | 10.6% |
| 10 yearsp.a. | 18.5% | 4.1% |
| Since inceptionp.a. | 8.6% | -2.1% |
| Year | Long leg | Long-short |
|---|---|---|
| 202611 mo | 13.3% | 21.2% |
| 2025 | 23.4% | -12.8% |
| 2024 | 29.6% | -8.7% |
| 2023 | 68.7% | 50.0% |
| 2022 | -34.8% | 8.7% |
| 2021 | 17.1% | -3.6% |
| 2020 | 38.3% | -11.7% |
| 2019 | 24.4% | -3.8% |
| 2018 | 0.8% | 12.3% |
| 2017 | 34.1% | 3.7% |
| 2016 | 9.7% | 4.3% |
| 2015 | 14.6% | 11.0% |
| 2014 | 2.1% | -6.0% |
| 2013 | 44.2% | -0.8% |
| 2012 | 17.6% | 9.7% |
| 2011 | -0.9% | -2.4% |
| 2010 | 14.6% | -0.6% |
| 2009 | 51.0% | 13.3% |
| 2008 | -34.8% | -13.7% |
| 2007 | 13.4% | -15.1% |
| 2006 | 10.9% | 5.1% |
| 2005 | -0.4% | -12.2% |
| 2004 | 0.5% | -11.7% |
| 2003 | 66.4% | 37.9% |
| 2002 | -36.8% | -11.7% |
| 2001 | -21.1% | -17.6% |
| 2000 | -38.0% | -26.1% |
| 1999 | 16.3% | -37.0% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through November 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
The Foundry Earnings Quality (Accruals) Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Earnings Quality (Accruals) signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,140-name universe at November 2026. Rows: Large ≥ $5.3B, Small < $832M. Columns: Value ≥ 0.62, Growth < 0.33 B/M. The dot marks the capital-weighted centroid of the book — 93% toward Large, 73% toward Growth. +7% unclassified (37 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → November 2026; the right-hand end is the same value as the box’s dot. 216 names now. Hypothetical holdings — descriptive, not P&L.